Innovations in Interstitial Lung Disease: Cellular Mechanisms and Translational Applications in Lung Fibrosis

Moderator(s)

• NB

  Nunzio Bottini, MD;PhD

  Cedars Sinai Medical Center
  Beverly Hills, CA, United States

  Disclosure(s): Tonix Pharmaceuticals: Consultant (Ongoing)
• 

  Benjamin Korman, MD

  University of Rochester
  Rochester, NY, United States

  Disclosure information not submitted.

Session Coordinator(s)

• 

  Monica Yang, MD

  UCSF
  San Francisco, CA, United States

  Disclosure information not submitted.

This innovative session will highlight new research in interstitial lung disease, with a specific focus on the immune contributions to fibrosis and translational applications.

Presentations:

• 8:30 AM - 9:00 AM Central Time

  Immune Mechanisms of Fibrotic Lung Disease
  

  Speaker: Edy Kim, MD, PhD – Brigham and Women's Hospital
• 9:00 AM - 9:30 AM Central Time

  Bench to Bedside: Translational Findings in SSc-ILD
  

  Speaker: Monique Hinchcliff, MD;MS – Yale School of Medicine